SOURCE: Xtalks

Xtalks Webinars

August 16, 2016 07:00 ET

An Integrated Bio-Pharmaceutics Approach for Effective Drug Development, New Webinar Hosted by Xtalks

­TORONTO, ON--(Marketwired - August 16, 2016) - This webinar presented for discovery, preclinical and formulation scientists and professionals, will demonstrate a joint, consultative approach to drug development. Featured speakers Robert Harris, Chief Technical Officer at Juniper Pharma Services and Richard Weaver, Founder and Managing Director at XenoGesis will explain how their unique Enabling Technologies Rapid Screen can help audience members take a compound through to clinic in a seamless, rapid and cost-effective way. The live broadcast takes place on Thursday, September 8, 2016 at 10am EDT (3pm BST/UK).

New drug candidates fail during development for many reasons, centered around:

  • Undesirable absorption and/or metabolism of the compound in man
  • Undesirable pharmacodynamics
  • Poor solubility over the physiological pH range
  • Poor stability of the compound in the gastrointestinal environment

With the constant demands on pharmaceutical scientists to reduce time and cost for development of new drugs, selecting the 'winners' and identifying the 'losers' in a selection of compounds can increase the chances of success in clinic and help achieve the drug development goals.

Juniper Pharma Services and XenoGesis work together successfully to provide an integrated bio-pharmaceutics service offering. The unique combined approach helps to remove the gap between 'chemical' and 'biological' to provide the most effective drug delivery solutions.

This approach can help pharmaceutical and biotechnology companies:

  • Predict how a drug will behave in vivo
  • Pave the way to human-optimized medicines
    • Maximize exposure for toxicological studies
    • Maximize or modify drug delivery for clinical trials
  • Optimize drug performance by tailored formulation strategy

To learn more about this complimentary event visit: An Integrated Bio-Pharmaceutics Approach for Effective Drug Development

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global Life Sciences community. Every year thousands of industry practitioners (from pharmaceutical & biotech companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/sponsorship.ashx

Image Available: http://www.marketwire.com/library/MwGo/2016/8/15/11G110554/Images/Juniper_logo_x200-159bdffec8329675950b6caae8bc8d44.jpg
Image Available: http://www.marketwire.com/library/MwGo/2016/8/15/11G110554/Images/XenoGesis_logo_x200-fec14cfe2f00ab7b978b1ba6f5bc4864.jpg

Contact Information